Pfizer's adjusted gross margin was 77% in Q3 2026. The reported drivers were favorable product mix and cost management. The quarter's adjusted operating margin was 36%, tempered by a $0.10-per-share Innovent transaction charge to adjusted EPS.
Key facts
Pfizer's adjusted gross margin was 77% in Q3 2026, reflecting favorable product mix and cost management. source
Pfizer's adjusted operating margin was 36% in Q3 2026, tempered by the Innovent AIPR&D charge. source